TrialBritish journal of cancer2019

Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study.

Yanjun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.